Binbin Yue
University of Maryland, Baltimore
28 Papers
105 Citations
Binbin Yue is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 8, co-authored 17 publications.
Chat about Author
Papers
Increased serum GP88 (Progranulin) concentrations in rheumatoid arthritis.
Yasuko Yamamoto,Masao Takemura,Ginette Serrero,Jun Hayashi,Binbin Yue,Aya Tsuboi,Hisako Kubo,Takashi Mitsuhashi,Kenji Mannami,Masao Sato,Hidetoshi Matsunami,Yushi Matuo,Kuniaki Saito +12 more
TL;DR: The concentrations of serum P GRN in RA were found to be significantly higher than those in age-matched healthy controls, although it remains to be clarified how blood PGRN is related to the pathogenesis of RA.
70
Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma
Ginette Serrero,Douglas M. Hawkins,Binbin Yue,Olga B. Ioffe,Pablo A. Bejarano,Jeffrey T. Phillips,Jonathan F. Head,Robert L. Elliott,Katherine R. Tkaczuk,Andrew K. Godwin,Jo Ellen Weaver,Wes E. Kim +11 more
TL;DR: Evidence is provided that GP88 provides prognostic information independent of tumor and clinical characteristics and would support prospective study to examine whether GP88 expression could help stratify patients with ER+ tumors for adjuvant therapy.
GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinoma.
Martin J. Edelman,Josephine Feliciano,Binbin Yue,Pablo A. Bejarano,Olga B. Ioffe,David Reisman,Douglas M. Hawkins,Qiwei Gai,David G. Hicks,Ginette Serrero +9 more
TL;DR: This is the first study demonstrating GP88 tissue and serum expression as a prognostic biomarker in localized and advanced disease and the potential of GP88expression as a predictive marker for anti-GP88 therapeutics.
56
Increased Circulating Level of the Survival Factor GP88 (Progranulin) in the Serum of Breast Cancer Patients When Compared to Healthy Subjects
Katherine Rak Tkaczuk,Binbin Yue,Min Zhan,Nancy Tait,Lavanya Yarlagadda,Huifang Dai,Ginette Serrero +6 more
- 12 Jul 2011
TL;DR: The data suggest that serial testing of serum GP88 levels may have value as a circulating biomarker for detection, monitoring and follow up of BC.
48
Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer.
TL;DR: The association of serum GP 88 level with survival and disease status suggests the potential of using the serum GP88 test for monitoring disease status in patients with MBC.
14